Aurinia Pharmaceuticals
AUPH
#5412
Rank
A$1.54 B
Marketcap
$10.80
Share price
0.00%
Change (1 day)
-16.88%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -A$64.53 M

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -A$64.36 M. In 2023 the company made an earning of -A$0.12 B an increase over its 2022 earnings that were of -A$0.17 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$64.53 M-42.41%
2023 -A$0.12 B-31.8%
2022 -A$0.17 B-39.4%
2021 -A$0.28 B61.9%
2020 -A$0.17 B-9.73%
2019 -A$0.19 B92.85%
2018 -A$96.18 M36.25%
2017 -A$70.59 M106.29%
2016 -A$34.22 M-15.4%
2015 -A$40.45 M65.84%
2014 -A$24.39 M129.82%
2013 -A$10.62 M-26.6%
2012 -A$14.46 M
2010 -A$8.19 M-39.22%
2009 -A$13.47 M-43.78%
2008 -A$23.96 M-53.19%
2007 -A$51.19 M42.97%
2006 -A$35.8 M-23.03%
2005 -A$46.52 M36.1%
2004 -A$34.18 M172.57%
2003 -A$12.54 M484.61%
2002 -A$2.15 M
2000 -A$10.19 M453.81%
1999 -A$1.84 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$6.88 B-10,791.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.23 M-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$22.89 M-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA